Lung Cancer (MET Gene Amplification): 2019 Multidisciplinary Molecular Tumor Board | ASCO Education
DISSECT platform with multi-omics data and various analytic tools - CNGBdb
Known and novel roles of the MET oncogene in cancer: a coherent approach to targeted therapy | Nature Reviews Cancer
Frontiers | The MET Oncogene as a Therapeutical Target in Cancer Invasive Growth
MET targeting: time for a rematch | Oncogene
IJMS | Free Full-Text | Targeting MET in Non-Small Cell Lung Cancer (NSCLC): A New Old Story?
C-Met - wikidoc
The multiple paths towards MET receptor addiction in cancer | Oncogene
MET in human cancer: germline and somatic mutations. | Semantic Scholar
The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping - Cancer Treatment Reviews
Imugex
MET (7q31) Orange + Copy Control 7 Green FISH Probe - Biocare Medical
MET Gene - GeneCards | MET Protein | MET Antibody
Understanding and Targeting MET Signaling in Solid Tumors - Are We There Yet?
Cancers | Free Full-Text | MET in Non-Small-Cell Lung Cancer (NSCLC): Cross ‘a Long and Winding Road’ Looking for a Target
Schematic representation of structures of the MET gene, MET, and its... | Download Scientific Diagram
What Is MET? - MET Crusaders
MET (7q31) Orange + Copy Control 7 Green - Biocare Medical
Lack of Association of C-Met-N375S Sequence Variant with Lung Cancer Susceptibility and Prognosis
MET Signaling: Novel Targeted Inhibition and Its Clinical Development in Lung Cancer - ScienceDirect
The role of MET in chemotherapy resistance | Oncogene
MET gene amplification is a mechanism of resistance to entrectinib in ROS1+ NSCLC - Tyler - 2022 - Thoracic Cancer - Wiley Online Library
MET Gene - GeneCards | MET Protein | MET Antibody
Targeting the MET gene for the treatment of non-small-cell lung cancer - ScienceDirect
